MECHANISMS FOR PITUITARY TUMORIGENESIS
MECHANISMS FOR PITUITARY TUMORIGENESIS
批准号:
6624736
负责人:
SHLOMO MELMED
金额:
$25.51万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-15 至 2003-11-30
关键词:
adenoma athymic mouse cell proliferation cell transformation chromosome walking fibroblast growth factor gene expression genetic library human genetic material tag human tissue hyperplasia immunocytochemistry in situ hybridization laboratory rat neoplasm /cancer genetics neoplastic growth neoplastic process neoplastic transformation northern blottings oncogenes oncoproteins pituitary neoplasms polymerase chain reaction pregnancy protein structure function
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Pituitary adenomas are common benign neoplasms giving rise to disorders of
growth, reproductive function, cortisol production and local central
pressure effects. Although recently determined to be monoclonal, the
genetic mechanisms involved in pituitary cell transformation are unclear.
This proposal will characterize the transforming properties of PTTG, a
novel pituitary tumor derived protein. We used differential RNA display to
identify a rat pituitary derived transforming gene (PTTG) which encodes a
199 a.a. novel protein. Now, we will isolate and study human PTTG and
assign its chromosomal locus. PTTG expression will be tested in hormone-
secreting (PRL, GH, ACTH) and non-functional pituitary tumors, and its
abundance assessed as a function of pituitary adenoma grading,
invasinenes, hormonal activity and ultimately long-term clinical outcome.
Cellular localization of PTTG will also be determined in these tumors by
double immunostaining and in situ techniques. Models of pituitary
enlargement (pregnancy and estrogen-induced prolactinomas) will be used to
determine PTTG expression in the pathogenesis of the pituicyte to
hyperplasia to adenoma formation. PTTG in vitro and in vivo transforming
properties will be determined in double agar transformation assays, nude
mouse tumorigenesis and growth factor regulation will be assessed. Effects
of inducible PTTG expression on cell proliferation will also be assessed.
These studies will thus provide mechanistic insight into the pathogenesis
of prolactinomas, acromegaly, Cushing's Disease and non-secreting
pituitary tumors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ph 2 Multicenter study of seliciclib for Cushing Disease IND 120,848 (10/10/2017)
-
批准号:10003845
-
项目类别:
-
资助金额:$46.78万
-
财政年份:2018
-
负责人:SHLOMO MELMED
-
依托单位:
Mechanisms for GH action on epithelial cells
-
批准号:10578571
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2018
-
负责人:SHLOMO MELMED
-
依托单位:
Mechanisms for GH action on epithelial cells
-
批准号:9893867
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2018
-
负责人:SHLOMO MELMED
-
依托单位:
Treatment of pituitary Cushing disease with a selective CDK inhibitor, R-roscovit
-
批准号:8773516
-
项目类别:
-
资助金额:$23.44万
-
财政年份:2014
-
负责人:SHLOMO MELMED
-
依托单位:
Cedars-Sinai Biobank and Translational Research Core Facility (CS-BRCF)
-
批准号:7935157
-
项目类别:
-
资助金额:$955.29万
-
财政年份:2010
-
负责人:SHLOMO MELMED
-
依托单位:
PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION
-
批准号:7606126
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2007
-
负责人:SHLOMO MELMED
-
依托单位:
MECHANISMS FOR PITUITARY TUMORIGENESIS
-
批准号:7606124
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2007
-
负责人:SHLOMO MELMED
-
依托单位:
MECHANISMS FOR PITUITARY TUMORIGENESIS
-
批准号:7376014
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2005
-
负责人:SHLOMO MELMED
-
依托单位:
PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION
-
批准号:7376016
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2005
-
负责人:SHLOMO MELMED
-
依托单位:
PITUITARY TUMOR SURVEILLANCE: PATHOGENETIC CORRELATION
-
批准号:7206322
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2004
-
负责人:SHLOMO MELMED
-
依托单位:
MECHANISMS FOR PITUITARY TUMORIGENESIS
-
批准号:7206320
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2004
-
负责人:SHLOMO MELMED
-
依托单位:
Metabolic consequences of securin disruption
-
批准号:7008190
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Metabolic consequences of securin disruption
-
批准号:6599784
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Metabolic consequences of securin disruption
-
批准号:7172931
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Metabolic consequences of securin disruption
-
批准号:6833420
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Pituitary Tumor Surveillance: Pathogenetic Correlation
-
批准号:7042064
-
项目类别:
-
资助金额:$1.41万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Metabolic consequences of securin disruption
-
批准号:6710585
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Mechanisms for Pituitary Tumorigenesis
-
批准号:7042061
-
项目类别:
-
资助金额:$1.41万
-
财政年份:2003
-
负责人:SHLOMO MELMED
-
依托单位:
Information Technology for Human Subjects Protection
-
批准号:6591413
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:SHLOMO MELMED
-
依托单位:
Gordon Research Conference on Prolactin
-
批准号:6623298
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2002
-
负责人:SHLOMO MELMED
-
依托单位:
海外基金